Microbiome contractor Arranta Bio announces construction of its commercial scale manufacturing plant is on schedule despite the pandemic.
FREMONT, CA: Arranta Bio ("Arranta"), a leading microbiome contract development and manufacturing company (CDMO), announced the mechanical completion of GMP suites at its Watertown, MA commercial-ready facility.
Arranta is investing above $100M in 2020 to set up a state-of-the-art, multi-product, commercial-ready manufacturing facility, which will supply live biotherapeutic products (LBPs) to microbiome innovator companies. The Watertown facility is designed to the highest specifications for advanced biologics production.
"We are grateful to the Arranta team and our construction management partner, DC Beane and Associates Construction Company, who specializes in the construction and development of life science facilities, and the numerous sub-contractors who have supported Arranta and worked through the pandemic in a safe and efficient manner to keep our commercial-ready manufacturing facility build-out on schedule. This is a remarkable accomplishment that will enable Arranta to supply vital products to patients in need and provide more than 200 new product development, manufacturing and operations jobs,” Mark Bamforth, President and CEO of Arranta Bio, said.
Arranta is also extending process development and GMP capacity at its early-clinical supply facility in Gainesville, FL.
Around 200 companies are exploring the linkage between various diseases and the microbiome—millions of bacteria, fungi, protozoa, and viruses that live within and on the human body—in order to identify therapeutic targets. Scientists have called the microbiome the second genome; the number of genes in the microbes making up one person's microbiome is estimated to be at least 200 times the number in the human genome.
In the past several years, the industry has experienced a swift acceleration in scientific understanding of the composition and functions of gut microbiota. Arranta is proud to be a leading CDMO that focuses on assisting the supply needs of these innovator companies.